A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure
Status:
Recruiting
Trial end date:
2024-01-22
Target enrollment:
Participant gender:
Summary
The main aim of this study is to check the safety of TAK-536. This study will take place in
Japan. At the first visit, the study doctor will check if each child can take part. For those
who can take part, each participant will have a check-up by the study doctor. This might take
2 weeks or longer.
After this, parents or the caregivers of each participant will be given sachets that contain
granules of TAK-536 to give to that participant. The participants will take the TAK-536
granules once a day for 52 weeks.
After treatment has finished, participants will visit the study clinic for a final check-up.